WINTON GROUP Ltd Purchases Shares of 14,000 Sanofi $SNY

WINTON GROUP Ltd purchased a new stake in Sanofi (NASDAQ:SNY) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 14,000 shares of the company’s stock, valued at approximately $678,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in SNY. Mondrian Investment Partners LTD purchased a new position in Sanofi in the 3rd quarter valued at approximately $171,742,000. Raymond James Financial Inc. boosted its position in Sanofi by 81.3% in the 2nd quarter. Raymond James Financial Inc. now owns 5,879,894 shares of the company’s stock valued at $284,058,000 after buying an additional 2,635,867 shares during the period. BNP Paribas Financial Markets boosted its position in Sanofi by 422.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,062,809 shares of the company’s stock valued at $50,165,000 after buying an additional 859,246 shares during the period. Victory Capital Management Inc. boosted its position in Sanofi by 133.3% in the 3rd quarter. Victory Capital Management Inc. now owns 1,413,640 shares of the company’s stock valued at $66,681,000 after buying an additional 807,767 shares during the period. Finally, Newport Trust Company LLC purchased a new position in Sanofi in the 4th quarter valued at approximately $37,421,000. Hedge funds and other institutional investors own 14.03% of the company’s stock.

Sanofi Price Performance

Shares of SNY opened at $43.57 on Thursday. Sanofi has a 1-year low of $42.28 and a 1-year high of $52.68. The stock has a market cap of $105.63 billion, a PE ratio of 12.17, a price-to-earnings-growth ratio of 1.10 and a beta of 0.34. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.01 and a quick ratio of 0.22. The firm has a fifty day moving average price of $45.29 and a 200 day moving average price of $46.60.

Sanofi Increases Dividend

The business also recently declared an annual dividend, which was paid on Wednesday, June 3rd. Investors of record on Monday, May 4th were given a $2.4225 dividend. This represents a yield of 559.0%. This is a boost from Sanofi’s previous annual dividend of $2.04. The ex-dividend date of this dividend was Monday, May 4th. Sanofi’s dividend payout ratio is presently 49.16%.

Analyst Ratings Changes

Several equities analysts have commented on SNY shares. Citigroup reissued a “neutral” rating on shares of Sanofi in a research report on Monday, April 13th. Weiss Ratings raised shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 13th. Argus raised shares of Sanofi to a “strong-buy” rating in a research report on Monday, April 27th. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research report on Thursday, March 19th. Finally, BNP Paribas Exane cut shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price objective for the company. in a research report on Monday, April 20th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $51.00.

Sanofi Company Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.